This observational study will follow patients requiring implantation of leadless pacemaker for 5 years after implantation. The main goal is to evaluate the long term safety and efficacy of AVEIRâ„¢ leadless pacemaker device in the usual clinical settings within the UK National Health Service. In addition, the study will collect data to understand patient characteristics receiving this type of pacemaker.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percentage of patients without complications related to the device or implantation procedure.
Timeframe: 5 years
Percentage of patients requiring re-intervention.
Timeframe: 5 years
Stimulation threshold (V) in the therapeutic zone
Timeframe: 5 years
Percentage of stimulation in the therapeutic zone
Timeframe: 5 years
Impedance (Ohm) of R waves in the therapeutic zone
Timeframe: 5 years
Amplitudes of R waves (mV) in the therapeutic zone
Timeframe: 5 years